Lymphatic staging in colorectal cancer: pathologic, molecular, and sentinel node techniques

Area of Science:

• Oncology
• Surgical Pathology

Background:

• Accurate colorectal cancer staging is vital for predicting prognosis and guiding adjuvant therapy decisions.
• While Stage III/Dukes C patients with lymphatic metastasis receive chemotherapy, some Dukes B2 patients without apparent metastasis experience relapse.
• Occult (micro)metastasis in lymph nodes is hypothesized as a cause for relapse in some colorectal cancer patients.

Purpose of the Study:

• To review literature on procedures aimed at improving lymph node staging in colorectal cancer.
• To assess the potential of identifying occult (micro)metastasis for improved patient stratification.
• To evaluate the prognostic significance and clinical utility of advanced lymph node staging techniques.

Main Methods:

• An extensive literature search was conducted using PubMed.
• Reference lists from identified articles were used to find additional relevant studies.
• A total of 30 articles describing original series on sentinel node biopsy in colorectal cancer were analyzed.

Main Results:

• Multiple techniques for enhancing lymph node staging in colorectal cancer have been described.
• The identification of occult (micro)metastasis demonstrated prognostic significance in most reviewed studies.
• The sentinel node technique, while promising, requires further follow-up studies to confirm its prognostic value in colorectal cancer.

Conclusions:

• Several methods exist to improve colorectal cancer staging by detecting occult metastasis.
• The prognostic significance of finding occult (micro)metastasis is established, but clinical significance remains unproven.
• Future studies are needed to determine if treating patients with detected occult metastasis using adjuvant therapy improves outcomes.